Valuation: Orthofix Medical Inc.

Market Cap 378M 332M 306M 286M 537M 35.7B 547M 3.67B 1.42B 17.6B 1.42B 1.39B 61.16B P/E 2026 *
-7.7x
P/E 2027 * -9.27x
Enterprise Value 378M 332M 306M 286M 537M 35.7B 547M 3.67B 1.42B 17.6B 1.42B 1.39B 61.16B EV / Sales 2026 *
0.45x
EV / Sales 2027 * 0.43x
Free-Float
97.81%
Yield 2026 *
-
Yield 2027 * -
1 day-1.07%
1 week-1.80%
Current month+0.11%
1 month-5.02%
3 months-22.21%
6 months-39.11%
Current year-38.79%
1 week 8.85
Extreme 8.85
9.62
1 month 8.85
Extreme 8.85
10.66
Current year 8.85
Extreme 8.85
16.42
1 year 8.85
Extreme 8.85
16.99
3 years 8.85
Extreme 8.85
21.6
5 years 8.85
Extreme 8.85
43.3
10 years 8.85
Extreme 8.85
74.44
Manager TitleAgeSince
Chief Executive Officer 54 2024-01-07
Director of Finance/CFO 55 2024-01-14
Compliance Officer - 2015-01-31
Director TitleAgeSince
Director/Board Member 66 2016-03-15
Director/Board Member 54 2020-06-07
Director/Board Member 64 2023-01-04
Date Insider Type Main position Quantity % Market Cap.
06-17Sell

Executive/Senior Manager

-3,670 0.0091%
06-09Free

Director

14,965 0.0370%
06-09Free

Director

14,965 0.0370%
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%-1.80%-14.63%-48.53% 378M
+3.33%+6.03%-31.78%-13.61% 158B
+1.78%+3.19%-4.77%-5.90% 103B
-0.87%-5.43%+51.86%+55.43% 54.49B
+1.92%+6.74%-0.74%+54.54% 55.35B
+2.92%+5.91%-10.77%-40.55% 40.72B
+3.25%+3.83% - - 30.48B
-0.29%-3.89%-17.75%-44.11% 26.91B
+2.87%+6.61%+58.19%-4.23% 24.05B
+0.43%-2.34%-18.17%-4.00% 19.91B
Average +1.43%-0.27%+1.27%-5.66% 51.25B
Weighted average by Cap. +2.06%+0.86%-5.39%+0.52%

Financials

2026 *2027 *
Net sales 844M 741M 683M 638M 1.2B 79.61B 1.22B 8.19B 3.17B 39.24B 3.17B 3.1B 136B 887M 780M 718M 672M 1.26B 83.74B 1.28B 8.62B 3.34B 41.28B 3.33B 3.26B 143B
Net income -47.49M -41.71M -38.43M -35.94M -67.4M -4.48B -68.64M -461M -179M -2.21B -178M -174M -7.68B -40.38M -35.47M -32.68M -30.56M -57.31M -3.81B -58.36M -392M -152M -1.88B -152M -148M -6.53B
Net Debt - -
Logo Orthofix Medical Inc.
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
1,605
Date Price Change Volume
26-06-25 US$9.280 -0.85% 50,449
26-06-24 US$9.360 +2.86% 333,035
26-06-23 US$9.100 +1.68% 337,121
26-06-22 US$8.950 -5.29% 363,613
26-06-18 US$9.450 +2.38% 504,124
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
9.360USD
Average target price
15.00USD
Spread / Average Target
+60.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OFIX Stock